India, Oct. 23 -- UNICEF and Gavi, the Vaccine Alliance, on Oct. 22, 2026 announced an agreement to cut the price of the RTS,S/AS01 malaria vaccine by approximately 40%, with UNICEF executing the deal and Gavi financially backing it. UNICEF said the agreement is expected to generate around US$50 million in savings between 2027 and 2029.
Price and timing
UNICEF said the deal, enabled through an advance payment by the International Finance Facility for Immunisation, will bring the price of the vaccine to EUR 5.50 per dose. The lower price is expected to take effect by early 2027.
UNICEF said the agreement is subject to regulatory and manufacturing milestones that must be met before UNICEF begins procuring doses.
The milestones include:
*...